| HOME >> BIOLOGY >> TECHNOLOGY |
SAN DIEGO, Oct. 3 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that the company is scheduled to provide a corporate overview of its clinical development and discovery programs at two upcoming investor conferences:
-- Natixis Bleichroeder Hidden Gems Conference
Presentation: Monday, October 8, 2007 at 8:00 a.m. Eastern Time (5:00
a.m. Pacific Time) at the Carlton Hotel on Madison Avenue in New York
City
Presenting: Robert E. Hoffman, Arena's Vice President, Finance and
Chief Financial Officer
-- BIO InvestorForum 2007
Presentation: Wednesday, October 10, 2007 at 2:15 p.m. Pacific Time
(5:15 p.m. Eastern Time) at the Palace Hotel in San Francisco
Presenting: Louis J. Scotti, Arena's Vice President, Marketing and
Business Development
A live audio webcast of each presentation will be available under the investor relations section of Arena's website at http://www.arenapharm.com. Replays of the presentations will be available for 30 days following the event. Please connect to Arena's website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.
About Arena Pharmaceuticals
Arena is a clinical-stage biopharmaceutical company focused on
discovering, developing and commercializing oral drugs in four major
therapeutic areas: cardiovascular, central nervous system, inflammatory and
metabolic diseases. Arena's most advanced product candidate, lorcaserin, is
being investigated in a Phase 3 clinical trial program for the treatment of
obesity. Arena's broad pipeli
'/>"/>
| SOURCE Arena Pharmaceuticals, Inc. Copyright©2007 PR Newswire. All rights reserved |